Uterine effects of raloxifene in comparison with continuous-combined hormone replacement therapy in postmenopausal women

This publication has 19 references indexed in Scilit:

• Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
  JNCI Journal of the National Cancer Institute, 1998
• Selective oestrogen receptor modulators: a new paradigm for HRT
  Current Opinion in Obstetrics and Gynecology, 1998
• Tamoxifen for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• Tamoxifen and the endometrium
  Published by Springer Nature ,1998
• Fortnightly review: Management of abnormal bleeding in women receiving hormone replacement therapy
  BMJ, 1997
• Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women
  The Lancet, 1997
• Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women
  JAMA, 1996
• Benefits and risks of estrogen replacement therapy
  American Journal of Obstetrics and Gynecology, 1995
• Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
  JAMA, 1995
• Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone
  American Journal of Obstetrics and Gynecology, 1994